Europe — EMA

Paklitaksel Sandoz (Paclitaxel)

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paklitaksel Sandoz, is a taxane presented as an intravenous solution for intravenous use. It treats various malignant neoplasms and is administered under the supervision of oncologists in hospital settings. GNH USA supplies Paklitaksel Sandoz as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Paklitaksel Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

What is Paclitaxel used for?

Paklitaksel Sandoz is a taxane chemotherapy agent used in solid tumour oncology.

- Breast cancer: Improves the overall response rate and survival when combined with anthracycline‑based regimens. - Ovarian cancer: Enhances the efficacy of platinum‑based therapy in first‑line treatment. - Non‑small cell lung cancer (NSCLC): Contributes to tumour shrink and disease control with tax‑‑ - \ \ \. - ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →